lmwh
- 网络低分子肝素(low molecular weight heparin)；低分子量肝素；低分子肝素钙
lmwhlmwh
低分子肝素(low molecular weight heparin)
低分子肝素 为观察低分子肝素（LMWH）治疗急性脑梗死的疗效及安全性，我科将2002年4月&mdash。2004年1月收治的60例 …
低分子量肝素
低分子量肝素（LMWH）的推荐用法：根据体重给药（anti－Xa IU／kg或mg/kg。不同低分子量肝素的剂量不同，详见下文）…
低分子肝素钙
低分子肝素钙（lmwh）是一种低分子量的肝素，由普遍肝素解聚而成，皮下注射后能形成有效的血浆肝素浓度，发挥其降低高 …
低分子肝素测定
...放试验 纤维蛋白肽A检测 肝素辅因子II活性测定 低分子肝素测定(LMWH) 磷酸葡萄糖变位酶（PGM）测定 血浆对氨基苯甲酸…
低分子肝素钠
目的:探讨低分子肝素钠(LMWH)对急性缺血性脑血管病(AIS)的治疗效果.方法:选取72例发病在72小时内的AIS患者,随机分为治 …
1
Application of low molecular weight heparins (LMWH) has been proven to be beneficial for the prevention of VTE in ischemic stroke patients.
对于缺血性卒中患者，使用低分子肝素已经证明可以有效预防VTE。
2
OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin(LMWH).
目的测定低分子肝素的分子量及其分布。
3
This study is to observe the clinical validity of the LMWH Sodium preventing and controlling the Henoch-Schoenlein Purpura Nephritis .
本研究旨在观察低分子肝素钠防治过敏性紫癜肾损害的临床有效性。
4
Conclusion: LMWH may be used as an early intervention method routinely in the treatment of ACS patients.
结论：低分子肝素可作为常规用于急性冠脉综合征患者的早期干预治疗。
5
Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulability in acute Kawasaki disease(KD).
目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。
6
Thesignificant inhibition effect of LMWH in liver cancer in animal experiments had already been reported.
国内有人在动物实验中发现LMWH有明显抑制肝癌生长和转移的作用。
7
In multiple randomized trials, including THA and TKA patients, LMWH has been more effective than warfarin in limiting overall DVT rates.
包括THA和TKA患者的多中心随机试验显示LMWH比华法林能更有效地减少总体DVT发生率。
8
International Circulation: Which LMWH would you normally choose to use in ACS patients?
《国际循环》：对ACS患者通常你会选择使用哪种低分子量肝素？
9
For these patients, we recommend subsequent anticoagulant therapy with VKA or LMWH indefinitely or until the cancer is resolved (Grade 1C).
对于上述患者，我们推荐接下来使用VKA或LMWH无限期抗凝治疗或者直到癌症缓解（1C）。
10
Objective To observe the effects of treatment and changes of hemorheology by using difibrase and LMWH to treat acute cerebral infarction.
目的观察降纤酶加低分子肝素治疗急性脑梗塞的临床疗效及血液流变学变化。
11
LMWH, Porcine low molecular weight heparin.
猪低分子肝素。
12
But on the whole, I think the evidence is that you can reduce the ischemic complications using LMWH compared with unfractionated heparin.
不过总体而言，我认为使用低分子量肝素相比普通肝素可以降低缺血性疾病的并发症。
13
The efficacy of LMWH is well documented.
LMWH的效果文献已有明确报道。
14
Objective: To observe the effect of DiHuang YinZi with LMWH in treating the brain obstruct.
目的：观察地黄饮子联合低分子肝素治疗脑梗塞的疗效。
15
Selection of the formula for the buccal tablets under lingua of LMWH and observation of the pharmacodynamics
低分子肝素舌下含片处方筛选及其药效观察
16
Efficacy and safety of reteplase and LMWH as reperfusion therapy in the patients with acute myocardial infarction
瑞替普酶并低分子肝素用于急性心肌梗死再灌注治疗的有效性与安全性研究
17
Effects of LMWH on Early Embryo of Rats in vitro Culture Added Sera of Women with Infertility or Spontaneous Abortion
应用早期鼠胚体外培养对低分子量肝素治疗不孕、自然流产妇女作用机理的初步研究
18
Analysis of anticoagulation effect of LMWH after percutaneous transluminal coronary angioplasty and stent
低分子肝素在经皮冠状动脉腔内成形术及支架术后抗凝疗效分析
19
Effects of low dose LMWH on pancreatic microcirculation in the rats of severe acute pancreatitis
小剂量低分子肝素对重症急性胰腺炎大鼠胰腺微循环的影响
20
Preparation of LMWH and the relationship between its structure and bioactivity
低分子肝素的制备方法及其结构与生物活性的关系